In This Article:
Wells Fargo lowered the firm’s price target on Agilon Health (AGL) to $4 from $8 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist.
Don't Miss our Black Friday Offers:
-
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
-
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AGL: